We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA, GSK: AIDS DRUGS MUST MEET TOP STANDARDS
PhRMA, GSK: AIDS DRUGS MUST MEET TOP STANDARDS
August 13, 2004
The brand industry is urging the FDA to strengthen standards for FDC HIV/AIDS drugs, even as the FDA moves forward with approving the first once-daily fixed-dose combination (FDC) products and a leading generic FDC AIDS drug producer faces concerns about its products’ bioequivalency standards.